Sign in
OMER Stock Price, Chart, Stats & News
Omeros Corporation
Save
Omeros Corporation (OMER) does not currently pay a dividend.
1.17B
Market cap
7.43x
Current P/E
87.72x
Forward P/E
OMER chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -65.24% |
ROE | 57.33% |
D/E | -0.87x |
Interest coverage ratio | -6.40x |
OMER valuation
P/E | 7.43x |
P/S | – |
P/B | -2.97x |
P/CF | -6.22x |
P/FCF | -6.65x |
P/OCF | -6.22x |
PEG | -1.27x |
EV multiple | -4.47x |
About
Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases. The company's therapeutic endeavors primarily focus on inflammatory conditions, illnesses mediated by the complement system, cancers linked to immune system dysregulation, and disorders characterized by addiction or compulsion. Its robust clinical pipeline features several promising candidates.
Similar securities
Based on sector and market capitalization
Report issue